LiveWire Ergogenics (LVVV) Stock Price, News & Analysis

Company Overview

LiveWire Ergogenics Inc., trading as LVVV on the OTC Markets, is a development‐stage company focused on next‐generation ergogenic and wellness solutions for athletes, fitness enthusiasts and active lifestyles. Founded in 2005 and headquartered in Boulder, Colorado, the company has evolved from a niche supplement provider into an integrated platform combining nutritional science, wearable technology and digital health analytics.

The firm’s core offerings include proprietary dietary formulations designed to support energy metabolism, muscle recovery and overall performance. Its flagship supplement candidate, ErgoMax Pro, blends branched‐chain amino acids with adaptogenic botanicals, while its LiveTrack mobile application uses artificial intelligence to analyze biomechanics and training load. In addition, LiveWire Ergogenics has developed wearable sensor modules that capture real‐time physiological data and feed directly into its cloud‐based health dashboard.

LiveWire Ergogenics distributes its products through a combination of e-commerce channels and selected retail partnerships across the United States. The company also collaborates with university research centers and independent laboratories in North America and Europe to conduct clinical studies and validate its formulations and algorithms. Plans are under way to expand into key markets in Western Europe and the Asia-Pacific region through strategic alliances and licensing agreements.

Under the guidance of an executive team with deep expertise in pharmaceutical research and development, sports nutrition, and digital technology, LiveWire Ergogenics pursues a multidisciplinary approach to innovation. The leadership group includes veterans in regulatory affairs, product commercialization and biomedical engineering, positioning the company to navigate the evolving landscape of biotech-enhanced fitness solutions and meet growing global demand.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0019
• Volume: 1,000 shs
• Average Volume: 2.16 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LVVV Stock Analysis - Frequently Asked Questions

How have LVVV shares performed this year?

LiveWire Ergogenics' stock was trading at $0.0006 at the start of the year. Since then, LVVV shares have decreased by 83.3% and is now trading at $0.0001.

How do I buy shares of LiveWire Ergogenics?

Shares of LVVV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of LiveWire Ergogenics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that LiveWire Ergogenics investors own include American Rebel (AREB), Pacific Biosciences of California (PACB), Docusign (DOCU), SuperCom (SPCB), Workhorse Group (WKHS), Carvana (CVNA) and Zion Oil & Gas (ZNOG).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Food Products
• Current Symbol: OTCMKTS:LVVV
• CIK: 1421289
• Web: www.livewireenergy.com
• Phone: (714) 740-5144
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A